- Home
- Publications
- Publication Search
- Publication Details
Title
Pediatric low-grade glioma in the era of molecular diagnostics
Authors
Keywords
-
Journal
Acta Neuropathologica Communications
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-12
DOI
10.1186/s40478-020-00902-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Larotrectinib in adult patients with solid tumours: a multicentre, open-label, phase I dose-escalation study
- (2019) D S Hong et al. ANNALS OF ONCOLOGY
- Larotrectinib: First Global Approval
- (2019) Lesley J. Scott DRUGS
- Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
- (2019) Zachary Miklja et al. NEURO-ONCOLOGY
- Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors
- (2019) Nozomi Matsumura et al. JOURNAL OF NEURO-ONCOLOGY
- Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
- (2019) Jason Fangusaro et al. LANCET ONCOLOGY
- Clinical utility of custom-designed NGS panel testing in pediatric tumors
- (2019) Lea F. Surrey et al. Genome Medicine
- Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
- (2019) Shuyan Dai et al. Cells
- Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
- (2019) Annika K. Wefers et al. ACTA NEUROPATHOLOGICA
- A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration
- (2019) Jason Chiang et al. ACTA NEUROPATHOLOGICA
- Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
- (2019) Ana S. Guerreiro Stucklin et al. Nature Communications
- Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations
- (2018) Annekathrin Reinhardt et al. ACTA NEUROPATHOLOGICA
- Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway
- (2018) Melike Pekmezci et al. ACTA NEUROPATHOLOGICA
- Myxoid glioneuronal tumor of the septum pellucidum and lateral ventricle is defined by a recurrent PDGFRA p.K385 mutation and DNT-like methylation profile
- (2018) David A. Solomon et al. ACTA NEUROPATHOLOGICA
- Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
- (2018) Maximilian Y. Deng et al. ACTA NEUROPATHOLOGICA
- Desmoplastic non- infantile astrocytoma/Ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation
- (2018) Debajyoti Chatterjee et al. HUMAN PATHOLOGY
- BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-Grade Glioma
- (2018) David T.W. Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- (2018) Theodore W Laetsch et al. LANCET ONCOLOGY
- Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas
- (2018) Romain Appay et al. MODERN PATHOLOGY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma
- (2018) Takuya Furuta et al. NEUROPATHOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- dPCR: A Technology Review
- (2018) Phenix-Lan Quan et al. SENSORS
- Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors
- (2018) Dazhi Liu et al. Therapeutics and Clinical Risk Management
- The genetic landscape of ganglioglioma
- (2018) Melike Pekmezci et al. Acta Neuropathologica Communications
- Trametinib for progressive pediatric low-grade gliomas
- (2018) Maria Kondyli et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Expanding the spectrum of pediatric NTRK -rearranged fibroblastic tumors to the central nervous system: A case report with RBPMS-NTRK3 fusion
- (2018) Matthew Torre et al. NEUROPATHOLOGY
- Identification of a novel KLC1–ROS1 fusion in a case of pediatric low-grade localized glioma
- (2018) Yoshiko Nakano et al. Brain Tumor Pathology
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma
- (2018) Fida Khater et al. ONCOGENE
- Optic Pathway Gliomas in Neurofibromatosis Type 1
- (2017) Cynthia J. Campen et al. JOURNAL OF CHILD NEUROLOGY
- BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas
- (2017) Xin Chen et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
- (2017) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- SHP2 regulates proliferation and tumorigenicity of glioma stem cells
- (2017) Laura Roccograndi et al. JOURNAL OF NEURO-ONCOLOGY
- Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System
- (2017) Scott Ryall et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Brigatinib effective in ALK-positive non-small-cell lung cancer
- (2017) Manjulika Das LANCET ONCOLOGY
- The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort
- (2017) Neval Ozkaya et al. MODERN PATHOLOGY
- PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation
- (2017) Candani S. A. Tutuka et al. Molecular Cancer
- Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors
- (2017) Shakti H. Ramkissoon et al. NEURO-ONCOLOGY
- A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
- (2017) Anuradha Banerjee et al. NEURO-ONCOLOGY
- Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy
- (2017) Patrick Y Wen et al. NEURO-ONCOLOGY
- K27M mutation inH3F3Ain ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway
- (2017) N. Joyon et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles
- (2017) P Jain et al. ONCOGENE
- Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions
- (2017) Pierre Vanden Borre et al. ONCOLOGIST
- Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
- (2017) Adrienne Johnson et al. ONCOLOGIST
- Non-optic glioma in adults and children with neurofibromatosis 1
- (2017) Laura Sellmer et al. Orphanet Journal of Rare Diseases
- Targeting TRK family proteins in cancer
- (2017) Yekaterina B. Khotskaya et al. PHARMACOLOGY & THERAPEUTICS
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway
- (2016) Jason T. Huse et al. ACTA NEUROPATHOLOGICA
- Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
- (2016) Barbara Rivera et al. ACTA NEUROPATHOLOGICA
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
- (2016) Ibrahim Qaddoumi et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study
- (2016) Rahul Krishnatry et al. CANCER
- Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort
- (2016) Gaelle Blanchard et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Identification ofZCCHC8as fusion partner ofROS1in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3)
- (2016) Mariela C. Coccé et al. GENES CHROMOSOMES & CANCER
- Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
- (2016) Alvaro Lassaletta et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1
- (2016) Elina Uusitalo et al. JOURNAL OF CLINICAL ONCOLOGY
- Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation
- (2016) Andrew J. Dodgshun et al. JOURNAL OF NEURO-ONCOLOGY
- Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
- (2016) Dong-Wan Kim et al. LANCET ONCOLOGY
- MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
- (2016) Pratiti Bandopadhayay et al. NATURE GENETICS
- Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
- (2016) Cassie N. Kline et al. NEURO-ONCOLOGY
- Desmoplastic infantile astrocytoma/ganglioglioma with rare BRAF V600D mutation
- (2016) Ashley Greer et al. PEDIATRIC BLOOD & CANCER
- Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic/chiasmatic glioma
- (2016) Alvaro Lassaletta et al. PEDIATRIC BLOOD & CANCER
- Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets
- (2016) Ying-Bei Chen et al. Nature Communications
- Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors
- (2016) Frédéric Fina et al. Oncotarget
- Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma
- (2016) Scott Ryall et al. Acta Neuropathologica Communications
- Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation
- (2016) Cordelia Orillac et al. Acta Neuropathologica Communications
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord
- (2015) Marco Gessi et al. ACTA NEUROPATHOLOGICA
- Pilocytic astrocytoma: pathology, molecular mechanisms and markers
- (2015) V. Peter Collins et al. ACTA NEUROPATHOLOGICA
- High rate of concurrent BRAF-KIAA1549 gene fusion and 1p deletion in disseminated oligodendroglioma-like leptomeningeal neoplasms (DOLN)
- (2015) Fausto J. Rodriguez et al. ACTA NEUROPATHOLOGICA
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- (2015) David A. Solomon et al. BRAIN PATHOLOGY
- A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer
- (2015) A. Drilon et al. CLINICAL CANCER RESEARCH
- Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
- (2015) A. L. Di Stefano et al. CLINICAL CANCER RESEARCH
- Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
- (2015) Midea Gierke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- BRAFMutation andCDKN2ADeletion Define a Clinically Distinct Subgroup of Childhood Secondary High-Grade Glioma
- (2015) Matthew Mistry et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum
- (2015) Claire Faulkner et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- KIAA1549
- (2015) Aline Paixão Becker et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies
- (2015) Paul A Northcott et al. LANCET ONCOLOGY
- Fusion genes withALKas recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
- (2015) Thale Kristin Olsen et al. NEURO-ONCOLOGY
- Successful Retreatment of a Child with a Refractory Brainstem Ganglioglioma with Vemurafenib
- (2015) Dolly Aguilera et al. PEDIATRIC BLOOD & CANCER
- Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
- (2015) Kasthuri Kannan et al. Oncotarget
- A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
- (2014) Sriram Venneti et al. ACTA NEUROPATHOLOGICA
- Pediatric low-grade gliomas: How modern biology reshapes the clinical field
- (2014) Guillaume Bergthold et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
- (2014) N. A. Brown et al. BLOOD
- Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
- (2014) R. Chakraborty et al. BLOOD
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
- (2014) David N. Louis et al. BRAIN PATHOLOGY
- Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation
- (2014) Shingo Tanaka et al. Brain Tumor Pathology
- FGFR1Mutations in Rosette-Forming Glioneuronal Tumors of the Fourth Ventricle
- (2014) Marco Gessi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
- (2014) Francesca del Bufalo et al. Journal of Translational Medicine
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas
- (2014) M. A. Karajannis et al. NEURO-ONCOLOGY
- Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007–2011
- (2014) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pilomyxoid astrocytoma treated successfully with vemurafenib
- (2014) Mary Skrypek et al. PEDIATRIC BLOOD & CANCER
- Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
- (2014) L. M. Kelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Advances in the Management of Low-Grade Gliomas
- (2014) Amulya A. Nageswara Rao et al. Current Oncology Reports
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
- (2013) Sonika Dahiya et al. ACTA NEUROPATHOLOGICA
- Pediatric Brainstem Gangliogliomas ShowBRAFV600EMutation in a High Percentage of Cases
- (2013) Andrew M. Donson et al. BRAIN PATHOLOGY
- Composite pleomorphic xanthoastrocytomaepithelioid glioneuronal tumor with BRAF V600E mutation â report of three cases
- (2013) Dara L. Aisner et al. CLINICAL NEUROPATHOLOGY
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF alterations in pediatric low grade gliomas and mixed neuronal–glial tumors
- (2013) Efthymios Dimitriadis et al. JOURNAL OF NEURO-ONCOLOGY
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
- (2013) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
- (2013) David T W Jones et al. NATURE GENETICS
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Exploring mechanisms of FGF signalling through the lens of structural biology
- (2013) Regina Goetz et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dysembryoplastic neuroepithelial tumor, a pure glial tumor? Immunohistochemical and morphometric studies
- (2013) Takashi Komori et al. NEUROPATHOLOGY
- CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry
- (2013) Suvendu Purkait et al. NEUROPATHOLOGY
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas
- (2013) A. J. Sievert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1
- (2013) L. A. Ramkissoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
- (2012) Xiao-Yang Liu et al. ACTA NEUROPATHOLOGICA
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Risk of benign tumours of nervous system and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study
- (2012) O O Seminog et al. BRITISH JOURNAL OF CANCER
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
- (2012) P. R. Gavine et al. CANCER RESEARCH
- IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
- (2012) YOSHIKO OKITA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Role and potential for therapeutic targeting of MYB in leukemia
- (2012) D R Pattabiraman et al. LEUKEMIA
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas
- (2012) C. Horbinski et al. NEURO-ONCOLOGY
- Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis
- (2012) M. J. Fisher et al. NEURO-ONCOLOGY
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
- (2012) D. Singh et al. SCIENCE
- Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma
- (2011) Huriye Cin et al. ACTA NEUROPATHOLOGICA
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- MAPK pathway activation in pilocytic astrocytoma
- (2011) David T. W. Jones et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?
- (2011) C. Hartmann et al. CLINICAL CANCER RESEARCH
- BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
- (2011) C. Hawkins et al. CLINICAL CANCER RESEARCH
- Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas
- (2011) K. Jacob et al. CLINICAL CANCER RESEARCH
- BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model
- (2011) E. H. Raabe et al. CLINICAL CANCER RESEARCH
- SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans
- (2011) Kun-Wei Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma
- (2011) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pediatric Low-Grade Gliomas
- (2011) Yongji Tian et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults
- (2011) M. Hasselblatt et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group
- (2011) Jeffrey H. Wisoff et al. NEUROSURGERY
- BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
- (2011) Dora Dias-Santagata et al. PLoS One
- MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas
- (2010) Ruth G. Tatevossian et al. ACTA NEUROPATHOLOGICA
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
- (2010) J. D. Schiffman et al. CANCER RESEARCH
- IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group
- (2010) Ian F. Pollack et al. CHILDS NERVOUS SYSTEM
- A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas
- (2010) D. A. Bax et al. CLINICAL CANCER RESEARCH
- On the death Trk
- (2010) Liraz Harel et al. Developmental Neurobiology
- Myb proteins: angels and demons in normal and transformed cells
- (2010) Ye Zhou Frontiers in Bioscience-Landmark
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
- (2010) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis
- (2010) K. A. Jaeckle et al. JOURNAL OF NEURO-ONCOLOGY
- Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
- (2010) Margaret J. Dougherty et al. NEURO-ONCOLOGY
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines
- (2010) A. A. Romano et al. PEDIATRICS
- Monoclonal antibody specific for IDH1 R132H mutation
- (2009) David Capper et al. ACTA NEUROPATHOLOGICA
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas
- (2009) Craig Horbinski et al. ACTA NEUROPATHOLOGICA
- Duplication of 7q34 in Pediatric Low-Grade Astrocytomas Detected by High-Density Single-Nucleotide Polymorphism-Based Genotype Arrays Results in a NovelBRAFFusion Gene
- (2009) Angela J. Sievert et al. BRAIN PATHOLOGY
- Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report
- (2009) Yasuo Sugita et al. Brain Tumor Pathology
- Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
- (2009) K Jacob et al. BRITISH JOURNAL OF CANCER
- Genetic alterations and signaling pathways in the evolution of gliomas
- (2009) Hiroko Ohgaki et al. CANCER SCIENCE
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors
- (2009) Fonnet E. Bleeker et al. HUMAN MUTATION
- MAPK pathway activation and the origins of pediatric low-grade astrocytomas
- (2009) Ruth G. Tatevossian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pediatric Low-Grade Gliomas
- (2009) Angela J. Sievert et al. JOURNAL OF CHILD NEUROLOGY
- Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing Deficits
- (2009) Thomas E. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma
- (2009) Thomas E. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
- (2009) Tim Forshew et al. JOURNAL OF PATHOLOGY
- Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
- (2009) Hilde Brems et al. LANCET ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
- (2008) Stefan Pfister et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncogenic mutations of ALK kinase in neuroblastoma
- (2008) Yuyan Chen et al. NATURE
- Neuroprotection by NGF and BDNF Against Neurotoxin-Exerted Apoptotic Death in Neural Stem Cells Are Mediated Through Trk Receptors, Activating PI3-Kinase and MAPK Pathways
- (2008) Nga Nguyen et al. NEUROCHEMICAL RESEARCH
- High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas
- (2008) H Deshmukh et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search